ulcerative colitis. Ulcerative colitis
Conditions
Interventions
Intervention 1: 80 Samples select from target population that assign at least 40 patients to each of two treatment arms.Patients in interventional group receive rose oil soft gel, two capsule three t
Treatment - Drugs
80 Samples select from target population that assign at least 40 patients to each of two treatment arms.Patients in interventional group receive rose oil soft gel, two capsule three times. oral, dail
Patients in control group receive placebo(Sesame Oil soft gel) two capsule three times,oral. daily for two months.
Sponsors
Shiraz University Of Medical Sciences and barijessence company
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients with ulcerative colitis that previously confirmed with colonoscopy ;age> 18-70 years. exclusion criteria: history of steroid use in the past 4 weeks; history of any NSAIDs use in one week before; history of antibiotic use within 2 weeks before entering the study; any medicinal plants within 2 weeks before entering the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms. Timepoint: in at first visit and then weekly during 2 months of treatment. Method of measurement: mayo clinic-6 standard form.;Quality of life. Timepoint: in at the beginning of the study and after 2 months of treatment. Method of measurement: IBDQ-9(Farsi version).;CRP test. Timepoint: Before the intervention and end of the intervention(2 months). Method of measurement: Device.;Fecal calprotectin. Timepoint: Before the intervention and end of the intervention(2 months). Method of measurement: stool exam. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effect. Timepoint: daily. Method of measurement: drug side effect registration questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactdr.Ali Tavakoli
Shiraz University Of Mdical Sciences
Outcome results
None listed